Call for applications for a patient advocacy representative member of the EASL Policy, Public Health, and Advocacy Committee
provide state-of-the-art scientific advice on all areas of liver health, research, treatment and liver disease prevention as required for the EASL PPHA work areas related to health and public policy, advocacy and…
People with cirrhosis and who receive a liver transplant are more susceptible to COVID-19 breakthrough infection
Study finds people with chronic liver disease and post-liver transplantation are at higher risk of getting infected with SARS-CoV-2 after COVID-19 primary series vaccination and identifies predictive factors associated with breakthrough infection.…
Liver Cancer Awareness Month – October 2023
Every October, we stand united for #LiverCancerAwarenessMonth, and EASL is proud to support this vital campaign. This month is a significant opportunity to raise awareness, educate, and advocate for liver health on…
Tribute to Prof. Gustav Paumgartner (1933-2023)
EASL mourns the loss of Gustav Paumgartner, a luminary in the field of hepatology and a true visionary. Born on November 23, 1933, Gustav's contributions to liver research and patient care have…
Next EASL SLD Summit
The EASL Governing Board is pleased to announce that the next EASL SLD Summit will take place in January 2025. The exact dates and location will be communicated soon. The Governing Board…
Call for Applications for Position of Editor-in-Chief, Journal of Hepatology
The Journal of Hepatology, EASL's flagships journal, has been in circulation since 1985. With an Impact Factor of 25.7 as of 2022, it stands as the foremost hepatology-exclusive journal. Journal of Hepatology…